Results 191 to 200 of about 2,930,776 (286)

sGC stimulator BAY 41‐8543 improves survival and ventricular function in a rat model of doxorubicin‐induced cardiomyopathy with nephrotic syndrome

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Anthracyclines such as doxorubicin (DOXO) remain a cornerstone of cancer therapy but are associated with a high risk of cardiotoxicity and subsequent heart failure (HF). Impairment of NO/soluble guanylyl cyclase (sGC)/cGMP pathway has been reported in anthracycline‐induced cardiomyopathy.
Olga Gawrys   +14 more
wiley   +1 more source

Bruton tyrosine kinase inhibitors and cardiovascular adverse events

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli   +4 more
wiley   +1 more source

MCL‐1 inhibition triggers a largely reversible cardiac stress signature in a humanised mouse model

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Myeloid cell leukaemia‐1 (MCL‐1) is an essential anti‐apoptotic protein and a promising therapeutic target in oncology. Early clinical studies of MCL‐1 inhibitors reported unexpected elevations in cardiac troponin, raising concerns about potential cardiotoxicity.
Markus B. Heckmann   +7 more
wiley   +1 more source

Emerging insights into amino acid metabolism in the heart: implications for cardiovascular diseases and therapeutic targeting

open access: yesBritish Journal of Pharmacology, EarlyView.
As a metabolically versatile organ, the heart is capable of generating energy from a wide range of substrates. Although fatty acid and glucose metabolism in the heart have been extensively studied, the contribution of amino acid metabolism to cardiac physiology and disease is gaining increasing attention.
Tayyiba Azam   +6 more
wiley   +1 more source

Consensus Statements on the Clinical Practice for Patients With Fontan‐Associated Liver Disease

open access: yesHepatology Research, EarlyView.
ABSTRACT The Fontan procedure has been transformative for patients with univentricular physiology. By using a single ventricle as the systemic pump and relying on passive venous return to drive pulmonary circulation, Fontan circulation alleviates cyanosis and heart failure, allowing children to engage in normal activities during school and adolescence.
Tatsuya Kanto   +13 more
wiley   +1 more source

Epidemiology and health burden of infective endocarditis: a comparative analysis of Australian vs global trends from 1990 to 2021

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Infective endocarditis (IE) is an uncommon but life‐threatening disease with evolving patient risk profiles and management strategies. However, its impact on the Australian healthcare system has not been described. Aims To quantify the healthcare burden of IE in Australia over time in the past three decades and compare outcomes with
David M. Chye   +9 more
wiley   +1 more source

Trajectory of macrotroponin in a community cohort

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Cardiac troponin I (cTnI) is a biomarker for myocardial injury. However, macrotroponin, a complex of cTnI and endogenous cardiac troponin autoantibodies, may artefactually elevate cTnI levels with potential to mislead clinicians, leading to inappropriate investigation and management.
Duncan J. Campbell   +5 more
wiley   +1 more source

Contemporary Outcomes of Catheter Ablation of Long‐Standing Persistent Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Advances in mapping and ablation have improved the safety and efficacy of catheter‐based ablation (CA) of atrial fibrillation (AF). Patients with long‐standing persistent atrial fibrillation (LSPAF) historically have poor ablation outcomes; however, they are underrepresented in contemporary reports.
Dakota De Cecco   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy